Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. That said, here is one large-cap stock that still has big upside potential and two that could be stalling.
Two Large-Cap Stocks to Sell:
Adobe (ADBE)
Market Cap: $92.94 billion
Originally named after Adobe Creek that ran behind co-founder John Warnock's house, Adobe (NASDAQ: ADBE) develops software products used for digital content creation, document management, and marketing solutions across desktop, mobile, and cloud platforms.
Why Is ADBE Not Exciting?
- Customers were hesitant to make long-term commitments to its software as its 13% average ARR growth over the last year was sluggish
- Estimated sales growth of 8.5% for the next 12 months implies demand will slow from its two-year trend
- Operating margin didn’t move over the last year, showing it couldn’t increase its efficiency
Adobe’s stock price of $229.68 implies a valuation ratio of 3.7x forward price-to-sales. Check out our free in-depth research report to learn more about why ADBE doesn’t pass our bar.
Fiserv (FISV)
Market Cap: $30.07 billion
Powering over 1 billion accounts and processing more than 12,000 financial transactions per second globally, Fiserv (NASDAQ: FISV) provides payment processing and financial technology solutions that enable merchants, banks, and credit unions to accept payments and manage financial transactions.
Why Does FISV Worry Us?
- Annual sales growth of 5.3% over the last two years lagged behind its financials peers as its large revenue base made it difficult to generate incremental demand
- Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 7% annually
- ROE of 9.4% reflects management’s challenges in identifying attractive investment opportunities
At $56.30 per share, Fiserv trades at 7x forward P/E. To fully understand why you should be careful with FISV, check out our full research report (it’s free).
One Large-Cap Stock to Watch:
Cardinal Health (CAH)
Market Cap: $50.78 billion
Operating as a critical link in the healthcare supply chain since 1979, Cardinal Health (NYSE: CAH) distributes pharmaceuticals and manufactures medical products for hospitals, pharmacies, and healthcare providers across the global healthcare supply chain.
Why Are We Positive On CAH?
- Massive revenue base of $244.7 billion in a highly regulated sector makes the company difficult to replace, giving it meaningful negotiating power
- Estimated revenue growth of 10.9% for the next 12 months implies demand will accelerate from its two-year trend
- Earnings growth has easily exceeded the peer group average over the last five years as its EPS has compounded at 10.2% annually
Cardinal Health is trading at $216.01 per share, or 19.8x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
